Atlas Trials

Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer

Clinical trial NCT05502913 · RECRUITING

Trial details

NCT number
NCT05502913
Sponsor
Soroka University Medical Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Lung Cancer
Start date
2023-09-01
Primary completion
2025-06-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.